Dilated cardiomyopathy and recurrent sustained ventricular tachycardia

5 September 2021
Organised by: Logo
Practice Tools Open Access Test your knowledge

The case

A 37-year-old male had been described as a healthy individual until he got severe flu with prolonged fever and fast heart rate.

After that:

  • left ventricular ejection fraction (LVEF) decreased to 45%
  • left ventricular thrombus was revealed
  • Paroxysmal atrial fibrillation (AFib) was developed

References

  1. Theresa A. McDonagh et al. - 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, European Heart Journal, 2021: 1-128 DOI: 10.1093/eurheartj/ehab368
  2. Micahel Glikson et al. – 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy, European Heart Journal, 2021: 1-94 DOI: 10.1093/eurheartj.ehab364
  3. Silvia G. Priori et al. – 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, European Heart Journal, 2015; 35: 2793-2867 DOI: 10.1093/eurheartj/ehv316
  4. Prashant D. Bhave – Renal denervation therapy for the treatment of arrhythmias: is the Sky the Limit? JAHA, 2017; 6:e005341 DOI: 10.1161/JAHA.116.005342
  5. Jason S Bradfield et al. – Renal denervation as adjunctive therapy to cardiac sympathetic denervation for ablation refractory ventricular tachycardia, Heart Rhythm, 2020; 17(2): 220-227 DOI: 10.1016/j.hrthm.2019.09.016
  6. Jonathan S. Steinberg et al. – Effect of renal denervation and catheter ablation vs. catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension, JAMA, 2020; 323(3): 248-255 DOI: 10.1001/jama.2019.21187

Notes to editor

authors:

Maria Simonenko1,2, Petr Fedotov2, Yulia Sazonova2

1EAPC Secondary Prevention and Rehabilitation nucleus member

2Almazov National Medical Research Centre, St. Petersburg, Russia

Contributors

ESC 365 is supported by